FindTrial
Sign In

Changes in clinical indicators after blood culture collection facilitate early identification of positive blood culture in adult COVID-19 patients with clinically suspected bloodstream infection

Changes in clinical indicators after blood culture collection facilitate early identification of positive blood culture in adult COVID-19 patients with clinically suspected bloodstream infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059362
Enrollment
Unknown
Registered
2022-04-28
Start date
2022-04-14
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Case series:None

Sponsors

Harbin Medical University First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. ICU admission in the COVID-19 Treatment Center of Heilongjiang Province; 2. Age >=18 years old; 3. Confirmed COVID-19 patients; 4. Blood culture collection due to clinically suspected BSI.

Exclusion criteria

Exclusion criteria: 1. Acquired immunodeficiency syndrome (AIDS); 2. Malignant tumors and leukemia patients receiving radiotherapy and/or chemotherapy within 6 months; 3. Organ transplant within 6 months; 4. Immunotherapy within 6 months; 5. Chronic organ failure; 6. Autoimmune disorder; 7. Pregnant or breastfeeding women; 8. Patients expected to die within 72 h; 9. Incomplete medical records.

Design outcomes

Primary

MeasureTime frame
PCT (Procalcitonin);Blood culture results;CRP;Inflammatory factor;—

Countries

China

Contacts

Public ContactKaijiang Yu

Harbin Medical University First Affiliated Hospital

yukaijiang001@sina.com+86 13521073979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026